COPD exacerbation medications (BNF)



Coding system
Pseudo BNF
Coding system release
84 (2023-02-01)
Organisation
University of Bristol
Codelist ID
bristol/copd-exacerbation-medications-bnf
Version ID
31f0f047

Versions
  • 31f0f047

Description

COPD exacerbation medication codes derived by Hannah Whittaker (Imperial College London) and reviewed by Jenni Quint (Imperial College London) for CONVALESENCE Long Covid EHR project


Codelists are developed by a broad community of users for individual study purposes, which may or may not meet the needs of other studies. They should not be thought of as universal definitions of a particular condition.

We don't offer any guarantees about what they do or don't identify. Users should carefully check that any codelist meets their needs, and seek clinical input where appropriate.

code term
0501011J0 Benzylpenicillin sodium (Penicillin G)
0501011P0 Phenoxymethylpenicillin (Penicillin V)
0501012G0 Flucloxacillin sodium
0501012H0 Flucloxacillin magnesium
0501012U0 Temocillin sodium
0501013B0 Amoxicillin
0501013C0 Amoxicillin sodium
0501013E0 Ampicillin
0501013K0 Co-amoxiclav (Amoxicillin/clavulanic acid)
0501013L0 Co-fluampicil(Flucloxacillin/ampicillin)
0501014N0 Ticarcillin with clavulanic acid
0501014S0 Piperacillin sodium/tazobactam sodium
0501015P0 Pivmecillinam hydrochloride
0603020T0 Prednisolone
0603020X0 Prednisone

Codes not in the full codelist are in faint grey.